Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Nuvectis Pharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +4 vs. Q4 2023
- Shares held
- 1.56M
- +48.7K (+3.2%) vs. Q4 2023
- Total value
- $12.8M
- +$187.8K (+1.5%) vs. Q4 2023
- New holders
- 6
- 16 more added
- Sold out
- 2
- 11 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 372,721 | $3.06M | 0.00% | −15,170−3.9% | Reduced |
| Vanguard Group Inc | 298,800 | $2.45M | 0.00% | +4,517+1.5% | Added |
| Baldwin Brothers Inc | 154,130 | $1.26M | 0.10% | +12,090+8.5% | Added |
| Geode Capital Management, LLC | 134,528 | $1.10M | 0.00% | +2,871+2.2% | Added |
| State Street Corp | 129,379 | $1.06M | 0.00% | +11,100+9.4% | Added |
| Northern Trust Corp | 62,097 | $509.2K | 0.00% | +523+0.8% | Added |
| Renaissance Technologies LLC | 61,700 | $506.0K | 0.00% | +9,900+19.1% | Added |
| Marshall Wace, LLP | 50,068 | $410.6K | 0.00% | +25,255+101.8% | Added |
| Morgan Stanley | 41,191 | $337.8K | 0.00% | +18,276+79.8% | Added |
| Millennium Management LLC | 39,501 | $323.9K | 0.00% | +5,490+16.1% | Added |
| Gsa Capital Partners LLP | 39,282 | $322.0K | 0.03% | +11,969+43.8% | Added |
| Forbes J M & Co LLP | 34,000 | $278.8K | 0.03% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 19,920 | $163.3K | 0.00% | 00.0% | Unchanged |
| Edmond de Rothschild Holding S.A. | 19,170 | $157.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,755 | $145.6K | 0.00% | −1,395−7.3% | Reduced |
| Blue Zone Wealth Advisors, LLC | 14,350 | $117.7K | 0.04% | +14,350 | New |
| Nuveen Asset Management, LLC | 11,883 | $97.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 10,293 | $84.4K | 0.00% | +39+0.4% | Added |
| UBS Group AG | 7,620 | $62.5K | 0.00% | −440−5.5% | Reduced |
| Rhumbline Advisers | 7,502 | $61.5K | 0.00% | +229+3.1% | Added |
| New York State Common Retirement Fund | 5,749 | $47.1K | 0.00% | −23−0.4% | Reduced |
| STRS Ohio | 5,800 | $47.0K | 0.00% | −400−6.5% | Reduced |
| JPMorgan Chase & Co | 5,165 | $42.4K | 0.00% | +263+5.4% | Added |
| Bank of America Corp | 3,775 | $31.0K | 0.00% | −3,730−49.7% | Reduced |
| American International Group, Inc. | 3,664 | $30.0K | 0.00% | −31−0.8% | Reduced |
| Deutsche Bank AG | 3,509 | $28.8K | 0.00% | +3,509 | New |
| Wells Fargo & Company | 2,200 | $18.0K | 0.00% | +298+15.7% | Added |
| Citigroup Inc | 1,382 | $11.3K | 0.00% | +274+24.7% | Added |
| Tower Research Capital LLC (TRC) | 851 | $6.98K | 0.00% | −427−33.4% | Reduced |
| Legal & General Group Plc | 841 | $6.90K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 747 | $6.13K | 0.00% | −477−39.0% | Reduced |
| Ameritas Investment Partners, Inc. | 566 | $4.64K | 0.00% | 00.0% | Unchanged |
| Trust Co of Vermont | 500 | $4.10K | 0.00% | +500 | New |
| FMR LLC | 435 | $3.57K | 0.00% | +433+21,650.0% | Added |
| Hollencrest Capital Management | 280 | $2.30K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 270 | $2.00K | 0.00% | −2,077−88.5% | Reduced |
| Amalgamated Bank | 231 | $2.00K | 0.00% | −739−76.2% | Reduced |
| NBC Securities, Inc. | 100 | $1.00K | 0.00% | +100 | New |
| GAMMA Investing LLC | 25 | $205 | 0.00% | +25 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 1 | $8 | 0.00% | +1 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −25,670−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,771−100.0% | Sold out |